Quick Answer
Zomedica Corp. reported Stockholders Equity of $115.40 million for fiscal year 2025.
Zomedica Corp. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $115.40M | -41.0% |
| 2024 | $195.66M | -18.5% |
| 2023 | $240.02M | -10.2% |
| 2022 | $267.39M | -1.3% |
| 2021 | $270.89M | +430.4% |
| 2020 | $51.07M | +2337.2% |
| 2019 | $2.10M | -42.7% |
| 2018 | $3.66M | -16.6% |
| 2017 | $4.39M | +14.4% |
| 2016 | $3.83M | +12.3% |
| 2015 | $3.41M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $119.69M | -41.0% | -4.5% |
| June 30, 2025 | $125.36M | -39.9% | -5.4% |
| March 31, 2025 | $132.44M | -42.9% | -32.3% |
| December 31, 2024 | $195.66M | -18.5% | -3.5% |
| September 30, 2024 | $202.84M | -22.2% | -2.8% |
| June 30, 2024 | $208.72M | -19.6% | -10.0% |
| March 31, 2024 | $231.90M | -11.8% | -3.4% |
| December 31, 2023 | $240.02M | -10.2% | -8.0% |
- Zomedica Corp. showed a decrease of -41.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2015–2025 period, Zomedica Corp.’s stockholders equity has grown by 3280.1% (from $3.41 million to $115.40 million).
- The most recent figure is from Zomedica Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: